Pharmalicensing brings you advice, commentary and analysis from industry experts.
EBD Group, the leading partnering firm for the life science industry, will hold the 18th annual BIO-Europe® international partnering conference in Hamburg, Germany November 12-14, 2012 at the CCH Congress Center Hamburg.
The 2012 conference is collaborating with ScanBaltTM fmba, the BioRegion association comprised of health and life science based sectors in the Nordic and Baltic countries, Poland, Northern Germany, Northwestern Russia and Northern Netherlands (ScanBalt BioRegion).
The event is also being held in collaboration with Norgenta, the service agency of Hamburg and the Federal State of Schleswig-Holstein, established to support life science activities in Northern Germany. "Life Science Nord" is the umbrella brand, under which the agency connects life science activities for different stakeholder groups to set up an internationally competitive cluster.
As Europe's largest partnering conference serving the global biotechnology industry, BIO-Europe® attracts the world's top dealmakers from biotech, pharma and finance along with exciting emerging companies.
"BIO-Europe is our premier European partnering event, and this year it will focus on opportunities for Nordic and North German companies to expand into global relationships.," said Carola Schropp, President of EBD Group. "The possibilities for collaboration are unlimited."
This year's opening plenary features industry staple Chris Morrison of Elsevier Business Intelligence as moderator for "New Investment Models for Early Stage Development." Speakers on the plenary include Hubert Birner of TVM Life Science Management GmbH, and Gilles Nobecourt of Edmond de Rothschild Investment Partners, both of whom have started new funds dedicated to the life science sector this year.
Partnering at BIO-Europe® 2012 is powered by partneringONE®, the leading conference networking solution for the life sciences. With partneringONE you can create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators. For more information go to: http://www.ebdgroup.com/bioeurope/partnering/index.php
The 2011 event boasted 14,765 scheduled one-to-one meetings with 3,565 licensing opportunities posted from among 1,596 companies that attended. Partnering remains the core drug development strategy of big pharma and biotech in the current economy.
Register for BIO-Europe before August 31, 2012 andl save EUR 200 off the regular registration rate: http://www.ebdgroup.com/bioeurope/registration/index.php
To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article please subscribe to our Pharmalicensing Intelligence service.
The opinions expressed in the articles published in this section do not necessarily reflect those of Pharmalicensing. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.
Clients in focus...